PetLife Pharmaceuticals, Inc. Retained Earnings
PetLife Pharmaceuticals, Inc. had Retained Earnings of -$31.28 million as of 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2018-07-17
- 2018-02-28: Retained Earnings (Accumulated Deficit) -$31.28M.
- 2017-11-30: Retained Earnings (Accumulated Deficit) -$30.85M.
- 2017-08-31: Retained Earnings (Accumulated Deficit) -$30.39M.
- 2017-05-31: Retained Earnings (Accumulated Deficit) -$28.39M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2018-02-28 | -$31.28M 10-Q · filed 2018-07-17 | |
| 2017-11-30 | -$30.85M 10-Q · filed 2018-01-22 | |
| 2017-08-31 | -$30.39M 10-Q · filed 2018-07-17 | |
| 2017-05-31 | -$28.39M 10-Q · filed 2017-07-18 | |
| 2017-02-28 | -$27.57M 10-Q · filed 2017-04-14 | |
| 2016-11-30 | -$26.25M 10-Q · filed 2017-02-10 | |
| 2016-08-31 | -$7.13M 10-K · filed 2017-12-15 | |
| 2016-05-31 | -$3.81M 10-Q · filed 2016-07-21 | |
| 2016-02-29 | -$3.68M 10-Q · filed 2016-04-19 | |
| 2015-11-30 | -$3.55M 10-Q · filed 2016-01-14 | |
| 2015-08-31 | -$3.44M 10-K · filed 2016-12-21 | -$3.45M 10-K · filed 2016-01-05 |
| 2015-05-31 | -$3.42M 10-Q · filed 2015-12-31 | |
| 2015-02-28 | -$3.41M 10-Q · filed 2015-12-31 | |
| 2014-11-30 | -$2.97M 10-Q · filed 2015-12-31 | |
| 2014-08-31 | -$1.51M 10-K/A · filed 2016-01-06 | |
| 2013-08-31 | -$38.00 10-K · filed 2015-12-31 |